Q77.4
Achondroplasia
Clinical Classification Guidelines
Inclusion Terms
- Hypochondroplasia
- Osteosclerosis congenita
Medical Intelligence & Overview
Achondroplasia is a genetic disorder characterized by abnormal bone growth, resulting in a form of dwarfism. It primarily affects the development of long bones, leading to distinctive physical features such as short stature and enlarged head. Despite these differences in appearance, individuals with achondroplasia typically have normal intelligence and health in other areas. The condition falls under the ICD-10 code Q77.4, serving as a classification in medical records and healthcare documentation. Understanding this condition can help in recognizing its features, underlying causes, symptoms, and available management options.
Causes & Symptoms
Clinical Causes: Achondroplasia is caused by a mutation in the FGFR3 gene, which encodes a protein involved in bone growth and development. This genetic mutation is usually inherited in an autosomal dominant pattern, meaning only one copy of the mutated gene is enough to cause the disorder. In many cases, the mutation occurs spontaneously during sperm or egg formation, leading to a new case without a family history. Hypochondroplasia and osteosclerosis congenita are related conditions with similar genetic mechanisms but differing clinical features.
Key Symptoms: Short stature, with an average adult height of around 4 feet (122 cm) Proportionate short limbs, especially notable in the arms and legs Large head with a prominent forehead and flattened nasal bridge Spinal curvature, such as lordosis or kyphosis Delayed motor skill development in childhood Normal intelligence and lifespan in typical cases Potential breathing issues related to airway obstruction or sleep apnea Ear infections due to structural differences in the ear canal Joint hypermobility or limited movement in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of achondroplasia is primarily clinical, based on physical features observed by a healthcare provider. Confirmatory testing involves genetic analysis to identify mutations in the FGFR3 gene. Prenatal ultrasound can suggest the diagnosis during pregnancy by detecting characteristic bone growth patterns. Genetic counseling is recommended for prospective parents with a family history of the condition or related skeletal abnormalities. Early detection allows for better planning and management of potential complications.
Treatment Protocols: Regular monitoring of growth and development by a team of specialists Surgical procedures to correct spinal stenosis, limb length discrepancies, or airway obstructions Physical therapy to improve mobility and muscle strength Hearing assessments and interventions for ear-related issues Educational support and psychological counseling as needed Potential use of growth hormone therapy, although its effectiveness varies
Clinical Advice & FAQs
Billing Guidance
Is Q77.4 a billable ICD-10 code?
Yes, Q77.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q77.4?
Clinical documentation must specify the nature of Achondroplasia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference